Distributing reliable information about medicines is challenging for the pharma industry and the healthcare professionals ...

Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol ...

The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...

Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study for VE303, a potential first-in-class ...

Tris Pharma, Inc. has announced positive results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol for ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Yet only 5% have an approved therapy, and none offers a cure, leaving a significant unmet medical need. Due to the limited ...

Alliance Healthcare UK has announced that Paula Sutherland has been appointed to the position of Sales Director. Paula will ...

Commit Biologics has announced the appointment of Janine Schuurman to its Board of Directors. Janine is a widely recognised ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a ...

AstraZeneca has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for ...

This initiative, funded by the Innovative Health Initiative Joint Undertaking (IHI JU) with over EUR 38 million, aims to ...